INBX
INBX
NASDAQ · Biotechnology

Inhibrx Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$128.79
-0.42 (-0.33%)
As of May 9, 1:36 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -85.9% upside
Low Target $12.39
Average Target $18.13
High Target $27.56
Current Price $128.79
Current
$128.79
Target
$18.13
$12.39 $18.13 avg $27.56
Scenario Analysis
Bear Case
$12.39
-90.4%
Low target
Base Case
$18.13
-85.9%
Avg target
Bull Case
$27.56
+-78.6%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$155.29
-17.1% from high
52-Week Low
$10.84
+1,088.1% from low
Target vs 52W High
$18.13
-88.3% vs high
Next Earnings Report
May 20, 2026
9d
until earnings
EPS Est: $-1.82
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%